Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Share News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.60
Bid: 9.60
Ask: 10.00
Change: -0.15 (-1.54%)
Spread: 0.40 (4.167%)
Open: 9.55
High: 9.60
Low: 9.55
Prev. Close: 9.75
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: HSBC Shares Fall Amid Investec Downgrade

Wed, 08th Jul 2020 10:45

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.

----------

FTSE 100 - LOSERS

----------

HSBC, down 4.1%. Investec downgraded the bank to Hold from Buy.

----------

WPP, down 3.6%. Credit Suisse reinitiated coverage of the advertising giant with Underperform.

----------

FTSE 250 - WINNERS

----------

Pantheon International, up 1.2%. The private equity investor said it expects a slight rise in annual net asset value, outperforming one benchmark but falling short of another. The investor said its net asset value at the May 31 year-end was 2,882.8 pence, up 4.0% year-on-year from 2,770.6p. The 4.0% gain compares favourably to the FTSE All-Share Index which returned negative 11% during the period. Pantheon lagged behind the MSCI World Index which returned 7.4%, however.

----------

FTSE 250 - LOSERS

----------

FirstGroup, down 15%. The Aberdeen-headquartered public transport company posted a GBP299.6 million pretax loss for the year ended March 31, widened from a GBP97.9 million loss the year before. This was due to operating costs, which rose 11% to GBP7.91 billion from GBP7.12 billion and more than offset FirstGroup's revenue rise of 8.7% to GBP7.75 billion from GBP7.13 billion. This resulted in a swing to a GBP152.7 million operating loss from a GBP9.8 million profit. FirstGroup said this swing "reflects charges relating to the North American self-insurance provision, Greyhound impairment charges, restructuring and reorganisation costs and coronavirus-related charges". Finance costs also increased to GBP149.6 million from GBP110.4 million. In March, average passenger volumes fell by around 90% by month end amid lockdowns and school closures in North America.

----------

Victrex, down 5.2%. The polymers manufacturer said sales volume for its third quarter to June 30 was 805 tonnes, down 12% from 912 tonnes in the comparative period the year prior. Revenue was down 18% year-on-year to GBP58.8 million. The decline was attributed to the negative impact of the Covid-19 crisis. Sales volume from the start of the year to June 30 was broadly in line with the previous year. Revenue fell to GBP210.3 million from GBP217.8 million, reflecting a 3% decline. Victrex said the Aerospace, Automotive & Energy markets experienced the greatest level of decline. The deferral of elective procedures in Medical started to hurt performance from April as monthly revenue declines of 40% was recorded however, it added market indicators suggest that procedure deferral will gradually reverse. Looking ahead, the Lancashire-based company said with lower production levels reflecting weaker demand and inventory reduction, and consequently the under-absorption of fixed costs as well as a weaker mix, it expects its margin to be further hurt in the second half and into financial 2020.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Distil, up 17%. The owner of premium drinks brands RedLeg Spiced Rum, Blackwoods Gin and Vodka said unaudited year-on-year first quarter revenue grew by 21%, thanks to an increase in domestic retail sales both in store and on-line across our product range. Volumes were flat in the three months to the end of June year-on-year. Looking forward, Distil said its expectations for the six-month period to September versus the same period prior year are for revenue to increase by between 75% and 85%, which will allow increased marketing investment. Operating profit is expected in the range of GBP50,000 to GBP70,000. In the six months to the end of September 2019, the company reported operating profit of GBP1,000 on turnover of GBP824,000 and marketing costs of GBP219,000.

----------

Hurricane Energy, up 7.2%. The exploration & production company said the 205/21a-6 well on the Lancaster field, offshore UK, has produced at an average rate of 12,000 barrels of oil per day during the second quarter of 2020. The increase in oil production from the 205/21a-6 well implemented on June 5 has, as expected, been accompanied by an increase in produced water. The combined oil production from the 205/21a-6 and 205/21a-7z wells, however, was 1.3 million barrels in the second quarter of 2020, down slightly from 1.4 million barrels reported in the fist quarter. Following the relaxation of Covid-19 restraints on UK offshore operations, on Friday last week the company said it began commissioning the electric submersible pumps in the Lancaster production wells.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

E-Therapeutics, down 24% at 13.13 pence. The Oxford, England-based drug discovery company reported a closure of retail offer, raiding GBP750,000. The company said it issued 6.3 million shares at a price of 12p each. The shares were placed at a 31% discount to the closing mid-price on Monday, the latest practicable date prior to the time and date of retail offer announcement. The retail offer is a part of E-Therapeutics' plans to raise up to GBP12.4 million through placing, subscription, retail offer and broker option. The company said it will use the funds raised to facilitate a number of initiatives to enable its next stage of growth and value creation by expanding its platform capabilities and asset pipeline.

----------

boohoo, down 22%. It is launching an immediate independent review of its UK supply chain, led by lawyer Alison Levitt. The fashion retailer said it is also accelerating its independent third party supply chain review with ethical audit and compliance specialists Verisio and Bureau Veritas. In addition, boohoo said it will be making an initial commitment to invest an incremental GBP10 million to eradicate supply chain malpractice. The move comes after Next and ASOS dropped boohoo clothing from their websites after claims that the fast-fashion retailer sold clothes made in factories where staff were paid less than the minimum wage and worked in poor conditions. boohoo has had more than GBP1 billion wiped from its share value in the past two days after an article in the Sunday Times newspaper alleged that workers in a Leicester factory making clothes destined for boohoo were being paid as little as GBP3.50 an hour.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
4 Jun 2015 15:22

AGM, EGM Calendar - Week Ahead

Read more
21 May 2015 08:23

e-Therapeutics Says First Patient Enrolled In Phase Ib ETS2101 Trial

Read more
31 Mar 2015 08:21

e-Therapeutics Loss Widens As It Increases Development Spending

Read more
26 Feb 2015 14:12

e-Therapeutics Believes Drug Discovery Process Producing Higher Yield

Read more
23 Jan 2015 13:36

UK DIRECTOR DEALINGS SUMMARY: Shanta Gold Non-Executive Sells Stake

Read more
21 Jan 2015 11:42

DIRECTOR DEALINGS: e-Therapeutics Finance Director Buys 150,000 Shares

Read more
16 Oct 2014 07:40

E-Therapeutics Appoints Sean Nicholson As Executive Director

Read more
16 Sep 2014 09:08

e-Therapeutics Loss Widens On Pipeline Development; Chair To Retire

Read more
9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

Read more
4 Jul 2014 16:30

Daily Mail General Trust's Chairman sells £15.91m-worth of shares

Viscount Rothermere, the Chairman of Daily Mail and General Trust, has traded in £15.91m-worth of shares in the multi-media and information company. Selling the stock at 860p a piece, Rothermere benefited from the rise seen in the group's share price this week, which has seen it climbed 5.56%, or

Read more
4 Jul 2014 08:59

DIRECTOR DEALINGS: e-Therapeutics Finance Chief Buys 100,000 Shares

Read more
25 Jun 2014 16:02

DIRECTOR DEALINGS: e-Therapeutics Non-Executives Allotted New Shares

Read more
12 May 2014 11:49

e-Therapeutics Loss Widens As It Continues Pipeline Development

LONDON (Alliance News) - e-Therapeutics PLC Monday posted a widened pretax loss for 2013 as it continued to invest and develop its pipeline of products. The pharmaceutical company posted a pretax loss of GBP6.1 million, widened from GBP5.0 million, as it upped its research and development e

Read more
8 May 2014 13:30

UK MIDDAY BRIEFING: Centrica Warns, Barclays Restructures

LONDON (Alliance News) - British gas parent Centrica has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians

Read more
8 May 2014 12:23

UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Barclays, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.